for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

ConvaTec Group PLC

CTEC.L

Latest Trade

200.80GBp

Change

-1.20(-0.59%)

Volume

326,844

Today's Range

200.80

 - 

206.40

52 Week Range

142.40

 - 

225.80

As of on the London Stock Exchange (LON) ∙ Minimum 15 minute delay

Pricing

Previous Close
202.00
Open
206.40
Volume
326,844
3M AVG Volume
93.79
Today's High
206.40
Today's Low
200.80
52 Week High
225.80
52 Week Low
142.40
Shares Out (MIL)
2,000.51
Market Cap (MIL)
4,106.03
Forward P/E
24.14
Dividend (Yield %)
2.19

Next Event

Half Year 2020 ConvaTec Group PLC Earnings Release

Latest Developments

More

GIC Private Discloses 3.0149% Stake In Convatec As Of May 12

Convatec Group ABO - Bookrunner Says Offering Size Approx. 120M Shares

Convatec Group Maintains 2020 FY Outlook

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About ConvaTec Group PLC

ConvaTec Group PLC is a United Kingdom-based medical product and technology company. The Company focuses on therapies for the management of chronic conditions, including products used for advanced chronic and acute wound care, ostomy care, continence and critical care and infusion devices used in the treatment of diabetes and other conditions. It operates across market franchises, such as Advanced Wound Care, which provides advanced wound dressings and skin care products; Ostomy Care, which provides devices, accessories and services for people with a stoma, resulting from colorectal cancer, inflammatory bowel disease, bladder cancer, obesity and other causes; Continence and Critical Care, which provides products for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida and other causes, and Infusion Devices, which provide disposable infusion sets.

Industry

Medical Equipment & Supplies

Contact Info

Fl 7, 3 Forbury Place, 23 Forbury Road

RG1 3JH

United Kingdom

https://www.convatecgroup.com/

Executive Leadership

John David Gibson McAdam

Independent Non-Executive Chairman of the Board

Karim Bitar

Chief Executive Officer, Executive Director

Frank Schulkes

Chief Financial Officer, Executive Director

Supratim Bose

President and Chief Operating Officer, Global Emerging Markets

Mani Gopal

President and Chief Operating Officer, Global Ostomy Care

Key Stats

2.44 mean rating - 16 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2017

1.8K

2018

1.8K

2019

1.8K

2020(E)

1.9K
EPS (USD)

2017

0.160

2018

0.160

2019

0.120

2020(E)

0.111
Price To Earnings (TTM)
536.61
Price To Sales (TTM)
2.94
Price To Book (MRQ)
3.41
Price To Cash Flow (TTM)
24.44
Total Debt To Equity (MRQ)
100.87
LT Debt To Equity (MRQ)
97.08
Return on Investment (TTM)
0.30
Return on Equity (TTM)
0.27

Latest News

Latest News

BRIEF-GIC Private Discloses 3.0149% Stake In Convatec As Of May 12

* GIC PRIVATE LTD DISCLOSES 3.0149% STAKE IN CONVATEC GROUP AS OF MAY 12 VERSUS PREVIOUS STAKE OF 8.9972% - FILING Source text for Eikon: Further company coverage:

BRIEF-Convatec Group ABO - Bookrunner Says Offering Size Approx. 120M Shares

* BLOCK TRADE: CONVATEC GROUP ABO - BOOKRUNNER SAYS OFFERING SIZE: APPROX. 120M SHARES Source text for Eikon: Further company coverage:

BRIEF-Convatec Group Maintains 2020 FY Outlook

* CONVATEC GROUP PLC - QTRLY GROUP REPORTED REVENUE OF $460 MILLION INCREASED 6.9% YEAR ON YEAR

BRIEF-Convatec Group FY Group Reported Revenue Of $1,827 Million Declined 0.3%

* CONVATEC GROUP PLC - RESULTS ON TRACK AND MAKING STRATEGIC PROGRESS

UPDATE 1-ConvaTec revenue falls on weak demand in Americas

Britain's ConvaTec Group Plc reported lower quarterly revenue on Friday as the medical products maker was hit by wilting demand in its biggest market, the Americas, while inventory troubles continued to plague the company back home.

ConvaTec logs softer 1st-qtr revenue on weak Americas business

ConvaTec Group Plc reported lower revenue for the first quarter on Friday, hit by wilting demand for some its older products and weaker income from the Americas, its biggest market.

UPDATE 1-Medical device maker ConvaTec names Genus top boss as CEO

British medical devices maker ConvaTec Group Plc on Monday named Genus Plc's top boss Karim Bitar as its chief executive officer and said Chairman Christopher Gent would retire from his role.

Medical device maker ConvaTec names Karim Bitar CEO

British medical devices maker ConvaTec Group Plc on Monday named Genus Plc's top boss Karim Bitar as its chief executive officer and said Chairman Christopher Gent would retire from his role.

ConvaTec to appoint Karim Bitar from Genus as CEO - Sky News

Catheter and colostomy bag maker ConvaTec Group Plc will on Monday appoint Karim Bitar as the company's chief executive officer, and will announce the departure of its Chairman Christopher Gent, Sky News reported on Sunday.

UPDATE 2-FTSE 100 squeezes out gains; ConvaTec drags midcaps

* ConvaTec slumps on mid-caps (Adds company news items, updates to closing prices)

ConvaTec's shares plummet on weak results, draws up turnaround plan

Shares of ConvaTec plunged on Thursday after the medical devices maker reported "disappointing" annual results and launched a turnaround plan, which would include a $150 million (117 million pounds) investment over three years to boost sales and profit.

Medical device firm ConvaTec adjusts for Brexit disruptions

Catheter and colostomy bag maker ConvaTec played down the risks of even a no-deal Brexit to its business on Thursday, saying it was making plans to stock pile appropriately to deal with any potential supply disruptions.

UPDATE 1-Britain's FTSE shrugs off Brexit impasse while Convatec and Superdry sink

* Warnings sink ConvaTec and Superdry (Updates prices, adds details)

ConvaTec shares plunge on profit warning and CEO departure

ConvaTec <CTEC.L> warned of lower sales and profitability and announced the departure of its CEO on Monday, sending shares in the British medical devices maker tumbling more than 30 percent.

ConvaTec slashes forecast on change in customer's inventory policy

British medical devices maker ConvaTec on Monday lowered its expectations for organic revenue and adjusted operating earnings margin for the full year, citing a change in inventory policy by its largest customer in its Infusion Devices business.

BRIEF-UBS Says Nordic Capital Sold 143.2 Mln Shares In Convatec

* NORDIC CAPITAL IT SOLD 143.2 MILLION ORDINARY SHARES IN CONVATEC GROUP PLC

UPDATE 1-Britain's ConvaTec Q1 revenue up 13.7 pct

British medical devices maker ConvaTec on Wednesday posted a 13.7 rise in first-quarter revenue, as acquisitions and favourable foreign exchange movements helped offset the persisting impact of supply chain disruptions in its businesses.

BRIEF-Convatec Group Q1 Group Revenue $458.2 Mln, Up 3.7 Pct

* 2018 FINANCIAL GUIDANCE RE-AFFIRMED: ORGANIC REVENUE GROWTH 2.5% TO 3.0%; ADJUSTED EBIT MARGIN 24% TO 25%

Britain's ConvaTec Q1 revenue up 13.7 pct

British medical devices maker ConvaTec on Wednesday posted a 13.7 rise in first-quarter revenue, as acquisitions and favourable foreign exchange movements helped offset the persisting impact of supply chain disruptions in its businesses.

BRIEF-Convatec Says Acquired J&R Medical LLC

* CONVATEC HAS DIVESTED ITS RESPIRATORY DELIVERY BUSINESS IN ARIZONA AND UTAH

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up